Imprimis Pharmaceuticals has lost its bid in California federal court to overturn a $48,500 jury award in a case brought by Allergan USA Inc. accusing its rival of using false advertisements to trick doctors into thinking its eye-treatment drugs used FDA-approved ingredients…

Read this piece in its entirety at Law360.